Literature DB >> 35211780

Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical cases.

Nick Corriveau-Lecavalier1, Mary M Machulda2, Hugo Botha1, Jonathan Graff-Radford1, David S Knopman1, Val J Lowe3, Julie A Fields2, Nikki H Stricker2, Bradley F Boeve1, Clifford R Jack3, Ronald C Petersen1, David T Jones4,5.   

Abstract

Diagnostic criteria for a progressive dysexecutive syndrome due to Alzheimer's disease (dAD) were proposed. Clinical observations suggest substantial variability in the clinico-radiological profiles within this syndrome. We report a case series of 6 patients with dAD highlighting this heterogeneity. Average age at diagnosis was 57.3 years, and patients were followed annually with clinical, cognitive, and multimodal imaging assessments for an average of 3.7 years. Cases were divided based into three subtypes based on their pattern of FDG-PET hypometabolism: predominantly left parieto-frontal (ldAD), predominantly right parieto-frontal (rdAD), or predominantly biparietal (bpdAD) (n = 2 for each). Prominent executive dysfunction was evidenced in all patients. ldAD cases showed greater impairment on measures of verbal working memory and verbal fluency compared to other subtypes. rdAD cases showed more severe alterations in measures of visual abilities compared to language-related domains and committed more perseverative errors on a measure of cognitive flexibility. bpdAD cases presented with predominant cognitive flexibility and inhibition impairment with relative sparing of working memory and a slower rate of clinical progression. rdAD and bpdAD patients developed neuropsychiatric symptoms, whereas none of the ldAD patients did. For each subtype, patterns of tau deposition relatively corresponded to the spatial pattern of FDG hypometabolism. dAD cases could be differentiated from two clinical cases of atypical AD variants (language and visual) in terms of clinical, cognitive and neuroimaging profiles, suggesting that dAD subtypes represent clinical entities separable from other variants of the disease. The recognition of distinct dAD phenotypes has clinical relevance for diagnosis, prognosis, and symptom management.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Atypical Alzheimer’s disease; Clinical neurology; Dysexecutive syndrome; FDG–PET; Neuropsychology

Mesh:

Substances:

Year:  2022        PMID: 35211780      PMCID: PMC9308626          DOI: 10.1007/s00415-022-11025-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  58 in total

Review 1.  Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer's disease: a review of 20 years of research.

Authors:  N Boublay; A M Schott; P Krolak-Salmon
Journal:  Eur J Neurol       Date:  2016-07-20       Impact factor: 6.089

2.  Ishihara color plates as a test for simultanagnosia.

Authors:  P W Brazis; N R Graff-Radford; N J Newman; A G Lee
Journal:  Am J Ophthalmol       Date:  1998-12       Impact factor: 5.258

Review 3.  The fractionation of working memory.

Authors:  A Baddeley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 4.  Are neuropsychiatric symptoms associated with evidence of right brain injury in referrals to a neuropsychiatric brain injury unit?

Authors:  L L Borek; R Butler; S Fleminger
Journal:  Brain Inj       Date:  2001-01       Impact factor: 2.311

5.  Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.

Authors:  N Andreasen; L Minthon; P Davidsson; E Vanmechelen; H Vanderstichele; B Winblad; K Blennow
Journal:  Arch Neurol       Date:  2001-03

Review 6.  Working memory: theories, models, and controversies.

Authors:  Alan Baddeley
Journal:  Annu Rev Psychol       Date:  2011-09-27       Impact factor: 24.137

7.  Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates.

Authors:  M M Bassiony; M S Steinberg; A Warren; A Rosenblatt; A S Baker; C G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2000-02       Impact factor: 3.485

8.  A fronto-parietal circuit for object manipulation in man: evidence from an fMRI-study.

Authors:  F Binkofski; G Buccino; S Posse; R J Seitz; G Rizzolatti; H Freund
Journal:  Eur J Neurosci       Date:  1999-09       Impact factor: 3.386

Review 9.  Frontotemporal dementia.

Authors:  Jee Bang; Salvatore Spina; Bruce L Miller
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

10.  Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

Authors:  Alexandre Bejanin; Daniel R Schonhaut; Renaud La Joie; Joel H Kramer; Suzanne L Baker; Natasha Sosa; Nagehan Ayakta; Averill Cantwell; Mustafa Janabi; Mariella Lauriola; James P O'Neil; Maria L Gorno-Tempini; Zachary A Miller; Howard J Rosen; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

View more
  2 in total

1.  Three cases of Creutzfeldt-Jakob disease presenting with a predominant dysexecutive syndrome.

Authors:  Nick Corriveau-Lecavalier; Wentao Li; Vijay K Ramanan; Daniel A Drubach; Gregory S Day; David T Jones
Journal:  J Neurol       Date:  2022-03-01       Impact factor: 6.682

2.  Failed Performance on the Test of Memory Malingering and Misdiagnosis in Individuals with Early-Onset Dysexecutive Alzheimer's Disease.

Authors:  Nick Corriveau-Lecavalier; Eva C Alden; Nikki H Stricker; Mary M Machulda; David T Jones
Journal:  Arch Clin Neuropsychol       Date:  2022-08-23       Impact factor: 3.448

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.